Skip to main content

Conference Features

General Psychiatry
September 16, 2019
Arshya Vahabzadeh, MD, understands the power neurotechnology can have in the lives of patients. The technology expert recently shared some thoughts on the future of psychiatry, which he will expand upon during his featured session at Psych Congress.
Psych Congress Year-Round
September 10, 2019
Psych Congress is pleased to announce on World Suicide Prevention Day that our 2019 charitable partner for the upcoming Congress in San Diego is the American Foundation for Suicide Prevention (AFSP).
General Psychiatry
September 04, 2019
BLOG: Currently, many of our patients are using cannabinoids, especially cannabidiol (CBD) to treat their own symptoms—ranging from insomnia, to anxiety, to depression.

More from the meeting

Psych Congress Year-Round
September 18, 2019
In concurrence with National Suicide Prevention Month, HMP, a leading healthcare education and events company, announced the launch of the Suicide Prevention 360 initiative.
Psych Congress Year-Round
September 17, 2019
Psych Congress has announced three new mental health experts will join its Steering Committee.
Abuse, PTSD & Trauma
August 14, 2019
A leading researcher on psychedelics sees late 2021 as the target date for MDMA to complete the transition from perceived party drug to legitimate prescription medication.
General Psychiatry
August 08, 2019
A series of advances in electroconvulsive therapy (ECT) have been made recently, with the aim of facilitating safe and effective use of the treatment for patients with certain severe mental health disorders.
Addiction Professional
July 31, 2019
The lifetime prevalence of a substance use disorder (SUD) hovers around 20% in the general population. The lifetime prevalence of chronic pain is about the same. Rates of both are much higher, however, in the psychiatric patient population.
Back to Top